Sworn enemies within the technology and pharmaceutical industries are joining forces in a lobbying drive to persuade European Union lawmakers to change a draft law they say will stifle innovation in Europe by criminalising patent infringements, along with all forms of intellectual property infringements.

8.8 per cent: The proportion of GDP that OECD countries spend on health.

The first investor-ready company has rolled off the production line in a scheme set up by the development agency Yorkshire Forward to commercialise research from the UK county's universities.

Just as most public research bodies embrace commercialisation as their raison d'etre, the UK Medical Research Council is reversing the trend and taking a company it span out earlier back within its fold.

Charges of scientific fraud in Korea aren't likely to faze Britain's ambitious stem-cell efforts, as evidenced by plans for a £40 million lab run by the 'father' of Dolly the sheep.

Diamonds are the hardest natural substance known to man, and hard to find too. But Russian scientists say they have found a way to make prospecting for the precious mineral much easier.

Cambridge University is tightening its grip on rights to intellectual property generated by staff and students after academics voted overwhelmingly to endorse new plans